Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Revenues $ 33,580 $ 22,116 $ 64,617 $ 46,377
Cost of goods sold 7,092 5,605 12,264 10,421
Gross profit 26,488 16,511 52,353 35,956
Costs and expenses:        
Sales and marketing 19,250 14,290 37,224 32,128
Research and development 5,723 4,071 11,471 8,685
General and administrative 8,669 6,404 17,032 11,906
Total costs and expenses 33,642 24,765 65,727 52,719
Loss from operations (7,154) (8,254) (13,374) (16,763)
Other (expense) income:        
Investment income 29 237 63 548
Interest expense (565) (31) (1,010) (62)
Change in fair value of derivatives (84) 0 (105) 0
Other expense (124) (57) (132) (20)
Total other (expense) income, net (744) 149 (1,184) 466
Net Loss $ (7,898) $ (8,105) $ (14,558) $ (16,297)
Weighted average common shares outstanding - basic (in shares) 41,080,898 39,823,414 40,894,405 39,760,602
Weighted average common shares outstanding - diluted (in shares) 41,080,898 39,823,414 40,894,405 39,760,602
Loss per common share - basic (in dollars per share) $ (0.19) $ (0.20) $ (0.36) $ (0.41)
Loss per common share - diluted (in dollars per share) $ (0.19) $ (0.20) $ (0.36) $ (0.41)